GE HealthCare
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Trade GE HealthCare 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About GEHC
GE Healthcare Technologies, Inc. engages in the development and manufacturing of medical technology, pharmaceutical diagnostics, and digital solutions. It operates through the following segments: Imaging, Advanced Visualization Solutions, Patient Care Solutions, and Pharmaceutical Diagnostics.
CEOPeter J. Arduini
CEOPeter J. Arduini
Employees53,000
Employees53,000
HeadquartersChicago, Illinois
HeadquartersChicago, Illinois
Founded1892
Founded1892
Employees53,000
Employees53,000
GEHC Key Statistics
Market cap37.53B
Market cap37.53B
Price-Earnings ratio17.01
Price-Earnings ratio17.01
Dividend yield0.17%
Dividend yield0.17%
Average volume3.52M
Average volume3.52M
High today$83.56
High today$83.56
Low today$82.11
Low today$82.11
Open price$82.20
Open price$82.20
Volume3.10M
Volume3.10M
52 Week high$94.80
52 Week high$94.80
52 Week low$57.65
52 Week low$57.65
Stock Snapshot
As of today, GE HealthCare(GEHC) shares are valued at $82.38. The company's market cap stands at 37.53B, with a P/E ratio of 17.01 and a dividend yield of 17.0%.
During the trading session on 2025-12-17, GE HealthCare(GEHC) shares reached a daily high of $83.56 and a low of $82.11. At a current price of $82.38, the stock is +0.3% higher than the low and still -1.4% under the high.
Trading volume for GE HealthCare(GEHC) stock has reached 3.1M, versus its average volume of 3.52M.
The stock's 52-week range extends from a low of $57.65 to a high of $94.80.
The stock's 52-week range extends from a low of $57.65 to a high of $94.80.
Analyst ratings
61%
of 23 ratingsBuy
60.9%
Hold
39.1%
Sell
0%
People also own
Based on the portfolios of people who own GEHC. This list is generated using Robinhood data, and it’s not a recommendation.